Stay updated on IRX-2 Regimen and Durvalumab Clinical Trial
Sign up to get notified when there's something new on the IRX-2 Regimen and Durvalumab Clinical Trial page.

Latest updates to the IRX-2 Regimen and Durvalumab Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe Record History now includes a new revision entry for v3.3.2 and removes the v3.2.0 revision.SummaryDifference0.1%

- Check20 days agoChange DetectedThe government funding lapse notice was removed from the page; this administrative notice did not change the trial data or eligibility details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check34 days agoChange DetectedNew version entries appear in the Record History with updated Study Status and Recruitment Status, reflecting ongoing updates to the trial record. The overall layout remains unchanged.SummaryDifference0.1%

- Check62 days agoChange DetectedNew operating-status notice and version update to v3.2.0 are now present, replacing the previous v3.1.0; this adds important information about potential funding-related service limitations and where to check for status.SummaryDifference10%

- Check69 days agoChange DetectedUpdated revision from v3.0.2 to v3.1.0, indicating a new version release with no other substantive content changes.SummaryDifference0.2%

- Check77 days agoChange DetectedThe page gains a newer date and a study status entry, and drops an older dated item, signaling a refresh to current information.SummaryDifference1%

Stay in the know with updates to IRX-2 Regimen and Durvalumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IRX-2 Regimen and Durvalumab Clinical Trial page.